Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema

BACKGROUND: The B(2) receptor antagonist icatibant is approved for treatment of attacks of hereditary angioedema. Icatibant has been reported to decrease time-to-resolution of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema in one study of European patients. METHODS: Patients wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Allergy Clin Immunol
Hlavní autoři: Straka, Brittany T., Ramirez, Claudia E., Byrd, James B., Stone, Elizabeth, Woodard-Grice, Alencia, Nian, Hui, Yu, Chang, Banerji, Aleena, Brown, Nancy J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705179/
https://ncbi.nlm.nih.gov/pubmed/27913306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.09.051
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky